A Genomic Approach to Improved Diagnosis and Treatment of Neuroendocrine Tumors
Demographics (3)
- AGE - Age at time of surgery (phv00397321.v3.p2)
- SEX - Gender of participant (phv00397322.v3.p2)
- SEX - Sex (phv00492288.v2.p2)
Other (21)
- AFFECTION_STATE - Affection status (phv00492289.v2.p2)
- ANALYTE_TYPE - Analyte type (phv00397328.v3.p2)
- BODY_SITE - Body site where sample was collected (phv00397327.v3.p2)
- CONSENT - Consent group as determined by DAC (phv00397311.v3.p2)
- HISTOLOGICAL_TYPE - Cell or tissue type or subtype of sample (phv00397330.v3.p2)
- IS_TUMOR - Tumor status (phv00397329.v3.p2)
- KI-67 - Ki-67 index of the subject (phv00397324.v3.p2)
- PRIMARY_METASTATIC_TUMOR - Primary tumor, metastasis, or transformed cell line (phv00397331.v3.p2)
- PRIMARY_SITE - Primary site of tumor (phv00397323.v3.p2)
- PRIMARY_TUMOR_LOCATION - Primary tumor location (phv00397332.v3.p2)
- SAMPLE_ID - De-identified sample ID (phv00397326.v3.p2)
- SAMPLE_ID - Sample ID (phv00397316.v3.p2)
- SAMPLE_SOURCE - Source repository where samples originate (phv00397317.v3.p2)
- SAMPLE_USE - Sample Use (phv00397319.v3.p2)
- SOURCE_SAMPLE_ID - Sample ID used in the Source Repository (phv00397318.v3.p2)
- SOURCE_SUBJECT_ID - Subject ID used in the Source Repository (phv00397313.v3.p2)
- STAGE - Cancer stage of patient (phv00397325.v3.p2)
- SUBJECT_ID - De-identified subject ID (phv00397320.v3.p2)
- SUBJECT_ID - Subject ID (phv00397310.v3.p2)
- SUBJECT_ID - Subject ID (phv00397315.v3.p2)
- SUBJECT_SOURCE - Source repository where subjects originate (phv00397312.v3.p2)